Ascendis Pharma (Brazil) Probability of Future Stock Price Finishing Over 28.63

A1SN34 Stock  BRL 53.35  1.65  3.00%   
Ascendis Pharma's future price is the expected price of Ascendis Pharma instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Ascendis Pharma AS performance during a given time horizon utilizing its historical volatility. Check out Ascendis Pharma Backtesting, Ascendis Pharma Valuation, Ascendis Pharma Correlation, Ascendis Pharma Hype Analysis, Ascendis Pharma Volatility, Ascendis Pharma History as well as Ascendis Pharma Performance.
  
Please specify Ascendis Pharma's target price for which you would like Ascendis Pharma odds to be computed.

Ascendis Pharma Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Ascendis Pharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Ascendis Pharma AS can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Ascendis Pharma AS had very high historical volatility over the last 90 days
The company reported the revenue of 7.78 M. Net Loss for the year was (383.58 M) with profit before overhead, payroll, taxes, and interest of 4.25 M.
Ascendis Pharma generates negative cash flow from operations

Ascendis Pharma Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Ascendis Stock often depends not only on the future outlook of the current and potential Ascendis Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Ascendis Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding56.9 M

Ascendis Pharma Technical Analysis

Ascendis Pharma's future price can be derived by breaking down and analyzing its technical indicators over time. Ascendis Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Ascendis Pharma AS. In general, you should focus on analyzing Ascendis Stock price patterns and their correlations with different microeconomic environments and drivers.

Ascendis Pharma Predictive Forecast Models

Ascendis Pharma's time-series forecasting models is one of many Ascendis Pharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Ascendis Pharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Ascendis Pharma AS

Checking the ongoing alerts about Ascendis Pharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Ascendis Pharma AS help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Ascendis Pharma AS had very high historical volatility over the last 90 days
The company reported the revenue of 7.78 M. Net Loss for the year was (383.58 M) with profit before overhead, payroll, taxes, and interest of 4.25 M.
Ascendis Pharma generates negative cash flow from operations

Additional Information and Resources on Investing in Ascendis Stock

When determining whether Ascendis Pharma AS is a strong investment it is important to analyze Ascendis Pharma's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ascendis Pharma's future performance. For an informed investment choice regarding Ascendis Stock, refer to the following important reports:
Please note, there is a significant difference between Ascendis Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ascendis Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ascendis Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.